Sociometric risk networks and risk for HIV infection

American Journal of Public Health

Volumn 87, Issue 8, 1997, Pages 1289-1296

  Friedman, Samuel R ^a   Neaigus, Alan ^a   Jose, Benny ^a   Curtis, Richard ^a   Goldstein, Marjorie ^a   Ildefonso, Gilbert ^a   Rothenberg, Richard B ^b   Des Jarlais, Don C ^c  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTACT EXAMINATION; EPIDEMIC; GROUP PSYCHOLOGY; HEALTH BEHAVIOR; HEALTH CARE PLANNING; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INTRAVENOUS DRUG ABUSE; RISK ASSESSMENT; SEROEPIDEMIOLOGY; SEROLOGY; SOCIAL INTERACTION;

EID: 0030741420     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.87.8.1289     Document Type: Article

References (56)

1. Auerbach DM, Darrow WW, Jaffe HW, Curran JW. Cluster of cases of the acquired immune deficiency syndrome: patients linked by sexual contact. Am J Med. 1984;76:487-492.
2. Friedman SR, Jose B, Neaigus A, et al. Consistent condom use in relationships between seropositive injecting drug users and sex partners who do not inject drugs. AIDS. 1994;8:357-361.
3. Neaigus A, Friedman SR, Goldstein M, Ildefonso G, Curtis R, Jose B. Using dyadic data for a network analysis of HIV infection and risk behaviors among injecting drug users. In: Needle RH, Coyle SL, Genser SG, Trotter RT, eds. Social Networks, Drug Abuse and HIV Transmission. Rockville, Md: National Institute on Drug Abuse; 1995:20-37. NIDA Research Monograph 151.
4. Rothenberg RB, Woodhouse DE, Potterat JJ, Muth SQ, Darrow WW, Klovdahl AS. Social networks in disease transmission: the Colorado Springs study. In: Needle RH, Coyle SL, Genser SG, Trotter RT, eds. Social Networks, Drug Abuse and HIV Transmission. Rockville. Md: National Institute on Drug Abuse; 1995:3-19. NIDA Research Monograph 151.
5. Rothenberg RB, Potterat JJ, Woodhouse DE, Darrow WW, Muth SQ, Klovdahl AS. The Colorado Springs study of social networks: observations on centrality. Soc Networks. 1995;17:273-297.
6. Potterat JJ, Woodhouse DE, Rothenberg RB, et al. AIDS in Colorado Springs: is there an epidemic? AIDS. 1993;7:1517-1521.
7. Woodhouse DE, Rothenberg RB, Potterat JJ, et al. Mapping a social network of heterosexuals at high risk for human immunodeficiency virus infection. AIDS. 1994;8:1331-1336.
8. Klovdahl AS, Potterat JJ, Woodhouse DE, et al. Social networks and infectious disease: the Colorado Springs study. Soc Sci Med. 1994;38:79-88.
9. Klovdahl AS. Social networks and the spread of infectious diseases: the AIDS example. Soc Sci Med. 1985;21:1203-1216.
10. Friedman SR, Neaigus A, Jose B, et al. Network and sociohistorical approaches to the HIV epidemic among drug injectors. In: Sherr L, Catalan J, Hedge B, eds. The Impacts of AIDS: Psychological and Social Aspects of HIV Infection. Chur, Switzerland: Harwood Academic Publishers; 1997: 89-113.
11. Curtis R, Friedman SR, Neaigus A, Jose B, Goldstein M, Ildefonso G. Street-level drug markets: network structure and HIV risk. Soc Networks. 1995;17:229-249.
12. Haraldsdottir S, Gupta S, Anderson RM. Preliminary studies of sexual networks in a male homosexual community in Iceland. J Acquir Immun Defic Syndr. 1992;5:374-381.
13. Neaigus A, Friedman SR, Curtis R, et al. The relevance of drug injectors' social networks and risk networks for understanding and preventing HIV infection. Soc Sci Med. 1994;38:67-78.
14. Trotter RT, Baldwin JA, Bowen AM. Network structure and proxy network measures of HIV, drug and incarceration risks for active drug users. Connections. 1995;18:89-104.
15. Trotter RT, Bowen AM, Potter JM. Network models for HIV outreach and prevention programs for drug users. In: Needle RH, Coyle SL, Genser SG, Trotter RT, eds. Social Networks, Drug Abuse and HIV Transmission. Rockville, Md: National Institute on Drug Abuse; 1995:144-180. NIDA Research Monograph 151.
16. Williams ML, Johnson J. Social network structures: an ethnographic analysis of intravenous drug use in Houston, Texas. Drugs Society. 1993;7:65-90.
17. Latkin CA. A personal network approach to AIDS prevention: an experimental peer group intervention for street-injecting drug users: the SAFE study. In: Needle RH, Coyle SL, Genser SG, Trotter RT, eds. Social Networks, Drug Abuse and HIV Transmission. Rockville, Md: National Institute on Drug Abuse; 1995:181-195. NIDA Research Monograph 151.
18. Potterat JJ, Rothenberg RB, Woodhouse DE. Gonorrhea as a social disease. Sex Transm Dis. 1985;12:25-32.
19. Rothenberg RB, Potterat JJ. Temporal and social aspects of gonorrhea transmission. Sex Transm Dis. 1988;15:88-95.
20. Garnett GP, Anderson RM. Contact tracing in the estimation of sexual mixing patterns: the epidemiology of gonococcal infections. Sex Transm Dis. 1993;20:181-191.
21. Friedman SR, Jose B, Deren S, Des Jarlais DC, Neaigus A, National AIDS Research Consortium. Risk factors for HIV seroconversion among out-of-treatment drug injectors in high-and low-seroprevalence cities. Am J Epidemiol. 1995;142:864-874.
22. Des Jarlais DC, Friedman SR. Ethnic differences in HIV seroprevalence rates among intravenous drug users. In: AIDS and Intravenous Drug Abuse among Minorities. Rockville, Md: National Institute on Drug Abuse; 1989:24-33. DHHS publication ADM 90-1637.
23. Friedman SR. Promising social network research results and suggestions for a research agenda. In: Needle RH, Coyle SL, Genser SG, Trotter RT, eds. Social Networks, Drug Abuse and HIV Transmission. Rockville, Md: National Institute on Drug Abuse; 1995:144-180. NIDA Research Monograph 151.
24. Trotter RT II, Rothenberg RB, Coyle S. Drug abuse and HIV prevention research: expanding paradigms and network contributions to risk reduction. Connections. 1995;18:29-45.
25. Seidman SB. Network structure and minimum degree. Soc Networks. 1983;5:269-287.
26. Wasserman S, Faust K. Social Network Analysis: Methods and Applications. Cambridge, England: Cambridge University Press; 1994.
27. Borgatti SP, Everett MG, Freeman LC. UCINET IV. Version 1.40/x. Columbia, SC: Analytic Technologies; 1992.
28. Des Jarlais DC, Friedman SR, Sotheran JL, et al. Continuity and change within an HIV epidemic: injecting drug users in New York City, 1984 through 1992. JAMA. 1994;271: 121-127.
29. Kahn HA, Sempos CT. Statistical Methods in Epidemiology. New York, NY: Oxford University Press; 1989.
30. Watters JK, Biernacki P. Targeted sampling: options for the study of hidden populations. Soc Problems. 1989;36:416-430.
31. Watters JK, Estilo MJ, Clark GL, Lorvick J. Syringe and needle exchange as HIV/ AIDS prevention for injection drug users. JAMA. 1994;271:115-120.
32. Williams ML. HIV seroprevalence among male IVDUs in Houston, Texas. Am J Public Health. 1990;1507-1509.
33. Tortu S, Beardsley M, Deren S, Davis WR. The risk of HIV infection in a national sample of women with injection drug-using partners. Am J Public Health. 1994; 84:1243-1249.
34. Rothenberg RB. Commentary: sampling in social networks. Connections. 1995;18: 105-111.
35. Frank O. Sampling and inference in a population graph. Int Stat Rev. 1980;48: 33-41.
36. Johnson JC, Boster JS, Holbert D. Estimating relational attributes from snowball samples through simulation. Soc Networks. 1989;11:135-158.
37. Anthony JC, Vlahov D, Nelson KE, et al. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. Am J Epidemiol. 1991;134:1175-1189.
38. Sasse H, Salmaso S, Conti S, et al. Risk behaviors for HIV-1 infection in Italian drug users: report from a multicenter study. J Acquir Immun Defic Syndr. 1989;2:486-496.
39. Jose B, Friedman SR, Neaigus A, et al. Syringe-mediated drug-sharing (backloading): a new risk factor for HIV among injecting drug users. AIDS. 1993;7:1653-1660.
40. Neaigus A, Friedman SR, Jose B, Goldstein M, Curtis R, Des Jarlais DC. Latino race/ethnicity and injecting at outside settings are HIV risk factors among new injectors. Presented at the 121st Annual Meeting of the American Public Health Association; 1993; San Francisco, Calif. Abstract 2199.
41. Schoenbaum EE, Hartel D, Selwyn PA, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med. 1989;321:874-879.
42. Chaisson RE, Bacchetti P, Osmond D, Brodie B, Sande MA, Moss AR. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA. 1989;261: 561-565.
43. Dasgupta S, Friedman SR, Jose B, et al. Using retrospective behavioral data to determine HIV risk factors among street-recruited drug injectors. J Drug Issues. 1995;25:161-171.
44. Novick DM, Trigg HL, Des Jarlais DC, Friedman SR, Vlahov D, Kreek MJ. Cocaine injection and ethnicity in parenteral drug users during the early years of the human immunodeficiency virus (HIV) epidemic in New York City. J Med Virol. 1989;29:181-185.
45. Levy PS, Lemeshow S. Sampling for Health Professionals. Belmont, Calif: Lifetime Learning Publications; 1980.
46. Goldstein M, Neaigus A, Jose B, Ildefonso G, Curtis R, Friedman SR. Self-reports of HIV risk behavior by injecting drug users: are they reliable? Addiction. 1995;90:1097-1104.
47. Neaigus A, Friedman SR, Jose B, et al. Syringe sharing and the social characteristics of drug-injecting dyads. Presented at the 121st Annual Meeting of the American Public Health Association; October 27. 1993; San Francisco, Calif. Abstract 3137.
48. Trotter RT, Potter JM, Bowen AM, Jiron D. Enfoques etnográficos y analisis de las redes sociales, para la creación de programmas de prevención del uso de drogas y de VIH en usarios activos. In: Las Adicciones: Hacia un Enfoque Multidisciplinario. Mexico City, Mexico: Secretaria de Salud, Consejo Nacional Contra las Adicciones; 1994:45-53.
49. Neaigus A, Friedman SR, Jose B, Curtis R, Goldstein M, Des Jarlais DC. HIV risk and protective behaviors among structurally central injecting drug users. Presented at the 123rd Annual Meeting of the American Public Health Association; November 1, 1995; San Diego, Calif. Session 2087.
50. Friedman SR, Wypijewska C. Social science intervention models for reducing HIV transmission. In: Assessing the Social and Behavioral Science Base for HIV/AIDS Prevention and Intervention: Workshop Summary - Background Papers. Washington, DC: National Academy Press; 1995: 53-74.
51. Latkin CA, Mandell W, Vlahov D, Oziemkowska M, Celentano D. The long-term outcome of a personal network-oriented HIV prevention intervention for injection drug users: the SAFE study. Am J Community Psychol. 1996;24:341-364.
52. Friedman SR, Des Jarlais DC. HIV among drug injectors: the epidemic and the response. AIDS Care. 1991;3:239-250.
53. Stimson GV. Reconstruction of subregional diffusion of HIV infection among injecting drug users in South-East Asia: implications for early intervention. AIDS. 1994;8:1630-1632.
54. Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health. 1996;86:642-654.
55. Friedman SR, Jose B, Neaigus A, Des Jarlais DC. Over the counter syringe sales and HIV in the United States. Presented at the Fifth Annual Conference on the Reduction of Drug-Related Harm; March 6-10, 1994; Toronto, Ontario, Canada. Session G2.
56. Des Jarlais DC, Friedman SR. HIV epidemiology and interventions among injecting drug users. Int J STD AIDS. 1996;7(suppl 2):57-61.